LESIONS OF THE VENTROLATERAL MEDULLA IN NORMAL AND VASOPRESSIN‐DEFICIENT (BRATTLEBORO) RATS

J. B. Minson; J. P. Chalmers

doi:10.1111/j.1440-1681.1984.tb00293.x

LESIONS OF THE VENTROLATERAL MEDULLA IN NORMAL AND VASOPRESSIN‐DEFICIENT (BRATTLEBORO) RATS

J. B. Minson, J. P. Chalmers

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

1. The cardiovascular response to electrolytic lesions of the A1 noradrenaline cell group (A1 lesion) were studied in the rat. 2. A1 lesions in normal rats cause acute hypertension and bradycardia and elevate plasma arginine‐vasopressin (AVP), as previously described in the rabbit. 3. After A1 lesions in vasopressin deficient rats the hypertension is not reduced compared to that seen in normal rats, but the bradycardia is attenuated. 4. AVP makes a greater contribution to the bradycardia than to the hypertension after A1 lesions.

Original language	English
Pages (from-to)	427-430
Number of pages	4
Journal	Clinical and Experimental Pharmacology and Physiology
Volume	11
Issue number	4
DOIs	https://doi.org/10.1111/j.1440-1681.1984.tb00293.x
Publication status	Published - Aug 1984

Keywords

A1 noradrenergic neurons
arterial pressure
heart rate
plasma vasopressin

Access to Document

10.1111/j.1440-1681.1984.tb00293.xLicence: In Copyright

Fingerprint Dive into the research topics of 'LESIONS OF THE VENTROLATERAL MEDULLA IN NORMAL AND VASOPRESSIN‐DEFICIENT (BRATTLEBORO) RATS'. Together they form a unique fingerprint.

Cite this

@article{08e164b389ca48c596f66b13645a8550,

title = "LESIONS OF THE VENTROLATERAL MEDULLA IN NORMAL AND VASOPRESSIN‐DEFICIENT (BRATTLEBORO) RATS",

abstract = "1. The cardiovascular response to electrolytic lesions of the A1 noradrenaline cell group (A1 lesion) were studied in the rat. 2. A1 lesions in normal rats cause acute hypertension and bradycardia and elevate plasma arginine‐vasopressin (AVP), as previously described in the rabbit. 3. After A1 lesions in vasopressin deficient rats the hypertension is not reduced compared to that seen in normal rats, but the bradycardia is attenuated. 4. AVP makes a greater contribution to the bradycardia than to the hypertension after A1 lesions.",

keywords = "A1 noradrenergic neurons, arterial pressure, heart rate, plasma vasopressin",

author = "Minson, {J. B.} and Chalmers, {J. P.}",

year = "1984",

month = aug,

doi = "10.1111/j.1440-1681.1984.tb00293.x",

language = "English",

volume = "11",

pages = "427--430",

journal = "Clinical and Experimental Pharmacology and Physiology",

issn = "0305-1870",

publisher = "Blackwell Science Asia",

number = "4",

}

TY - JOUR

T1 - LESIONS OF THE VENTROLATERAL MEDULLA IN NORMAL AND VASOPRESSIN‐DEFICIENT (BRATTLEBORO) RATS

AU - Minson, J. B.

AU - Chalmers, J. P.

PY - 1984/8

Y1 - 1984/8

N2 - 1. The cardiovascular response to electrolytic lesions of the A1 noradrenaline cell group (A1 lesion) were studied in the rat. 2. A1 lesions in normal rats cause acute hypertension and bradycardia and elevate plasma arginine‐vasopressin (AVP), as previously described in the rabbit. 3. After A1 lesions in vasopressin deficient rats the hypertension is not reduced compared to that seen in normal rats, but the bradycardia is attenuated. 4. AVP makes a greater contribution to the bradycardia than to the hypertension after A1 lesions.

AB - 1. The cardiovascular response to electrolytic lesions of the A1 noradrenaline cell group (A1 lesion) were studied in the rat. 2. A1 lesions in normal rats cause acute hypertension and bradycardia and elevate plasma arginine‐vasopressin (AVP), as previously described in the rabbit. 3. After A1 lesions in vasopressin deficient rats the hypertension is not reduced compared to that seen in normal rats, but the bradycardia is attenuated. 4. AVP makes a greater contribution to the bradycardia than to the hypertension after A1 lesions.

KW - A1 noradrenergic neurons

KW - arterial pressure

KW - heart rate

KW - plasma vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0021688589&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1681.1984.tb00293.x

DO - 10.1111/j.1440-1681.1984.tb00293.x

M3 - Article

C2 - 6518671

AN - SCOPUS:0021688589

VL - 11

SP - 427

EP - 430

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 4

ER -